Breaking News

Vetter Expands Clinical Development and Manufacturing Offerings

Expansion of production capacities and services at its Austrian site to double production volume.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Vetter, a global CDMO, is expanding capacities and services for the provision of clinical trial materials with the additional equipment for aseptic production and the expansion of storage capacities at the clinical site in Rankweil, Austria.    Vetter has successfully completed the first year of production in Rankweil and is preparing to further increase production capacities and capabilities on site. With 14 batches already filled in the first quarter of 2023, the number of batches produced i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters